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Abstract
Background: Developing tools to identify chronic rhinosinusitis with nasal polyps (CRSwNP) patients requiring surgical
treatment would help clinicians treat patients more effectively. The aim of this retrospective cross-sectional study was to
identify cut-off values for eosinophil percentage, nasal polyps (NP), and Lund-Mackay (LM) scores that may predict the need
for surgical treatment in Finnish CRSwNP patients.
Methods: Data of CRSwNP patients (N¼ 378) undergoing consultation for ESS in 2001–19 were used. Data was collected
from patient records and Lund-Mackay scores were determined from sinus computed tomography scans. The percentage of
eosinophils was microscopically evaluated from the polyp samples available (n¼ 81). Associations were analyzed by Mann
Whitney U test, and cut-off values by the area under the receiver operating characteristic curve (AUROC).
Results: ESS was performed to 293 (77.5%) of patients. Polyp eosinophilia was associated significantly with ESS (p¼ 0.001),
whereas peripheral blood eosinophil count, LM- score and endoscopic NP- score were not (p> 0.05). AUROC values (95% CI) for
detecting those needing ESS were for polyp eosinophilia 0.71 (0.60–0.83), p¼ 0.001, for LM score 0.59 (0.50–0.67), p¼ 0.054; for
NP score 0.56 (0.48–0.64), p¼ 0.17, and for blood eosinophil count 0.68 (0.46–0.90), p¼ 0.08. With the threshold value of polyp
eosinophilia (>25%), the sensitivity and specificity were optimal for detecting the group needing ESS from the group not undergoing
ESS. The cut-off value of blood eosinophil count (>0.26 109/L) had relatively good, yet statistically insignificant (underpowered),
predictive potential. Moderate cut-off values were found for endoscopic LM score (14/24) and NP score (4/8).
Conclusions: Polyp eosinophilia (>25%) predicted ESS among Finnish hospital-level CRSwNP patients. A future challenge
would be to find less invasive and cost-effective clinical factors predicting uncontrolled CRSwNP.
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Introduction
Chronic rhinosinusitis (CRS) lowers patients’ quality of
life substantially1 and in spite of appropriate guideline-
based care CRS is uncontrolled in up to 30–44%.1–3 The
two phenotypes of CRS, with nasal polyps (CRSwNP)
and without nasal polyps (CRSsNP) are thought to have
different etiologies1,4,5 and they also differ on the degrees
of inflammation with type 2 inflammation and eosino-
philia being more common in CRSwNP.1
CRSwNP is a common condition, and its prevalence
varies between 1 and 4%.6–8 Up to 45% of the CRSwNP
patients will develop asthma, and 8–26% cannot tolerate
non-steroidal anti-inflammatory drugs (NSAIDs) having
NSAID-exacerbated respiratory disease (NERD), also
called aspirin exacerbated respiratory disease
(AERD).1,9–11 In the NERD there is found a strong
eosinophilic hyperplastic inflammation on the mucosa
of the common airways.12
Patients with uncontrolled CRS after appropriate
medical treatment will usually undergo endoscopic
sinus surgery (ESS). Patients with CRSwNP have more
often recurrence of disease than CRS patients without
nasal polyps, but they seem to benefit from surgery
equally.2,13–15 Need for revision surgery in CRS has
been associated with gender, young adults, smoking,
allergic rhinitis (AR), occupational exposure, previous
sinus surgery, presence of nasal polyps, need for systemic
medication, asthma and NERD.16–22
Factors arising from clinical examination and tests
predicting need for surgery or revision surgery in CRS
have been widely investigated. Several clinical markers
raising the risk of recurrence have been reported: tissue
eosinophilia,3,23–25 serum eosinophilia,3 high computed
tomography (CT) scores,1,3,26 higher preoperative endo-
scopic Lund-Kennedy scores for polyposis,27 radiologi-
cal inflammatory findings in frontal sinuses17 and
changes in SNOT-22 scoring after surgery.28
Studies in Chinese Hospital population have pro-
posed cut-off values of uncontrolled CRS, such as
Lund-Mackay (LM) score of sinus CT scans 15 of
CRS patients3 and tissue eosinophilia 20% of
CRSwNP patients.29 In a study of Chinese CRSwNP
patients the optimal cut-off percentage value of nasal
polyp eosinophilia was 27% for predicting polyp recur-
rence in CRSwNP.30 Peripheral blood eosinophilia has
shown to be associated with eosinophilic CRSwNP.31
Concordant blood eosinophilia (0.3 109/L) and
tissue eosinophilia (10%) has shown to be related to
a higher likelihood of poor disease control of
CRSwNP.29
Yet there is limited knowledge of optimal cut-off
values of eosinophilia in other populations, and – gen-
erally – of endoscopic nasal polyp (NP) score in uncon-
trolled CRS. Therefore, the aim of the present study was
to identify cut-off values of nasal polyp eosinophilia,
peripheral blood eosinophilia, LM and NP score




This retrospective follow-up study was carried out in the
Departments of Otorhinolaryngology, at Tampere,
Kuopio and Helsinki University Hospitals, and P€aij€at-
H€ame Central Hospital between 2001 and 2019. The
study (nro 31/13/03/00/2015 and nro R07039) was
approved by the ethical committee of the Hospital
Districts.
Data of a total of 378 CRSwNP patients undergoing
CRS surgical consultation at the Departments of
Otorhinolaryngology between 2001 and 2019 was used.
Inclusion criteria were: age >16 years, available patient
record data of endoscopic nasal polyps during visit, and
available data of ESS within one year after the consul-
tation visit. CRSwNP was diagnosed according to the
European Position Paper on CRS and nasal polyps
(NPs).32
The background data (age, gender, smoking habits,
allergic rhinitis, asthma, NERD, previous ESS, baseline
ESS) were collected from the hospitals’ patient records.
Asthma, NERD and AR diagnoses were based on self-
reported doctor-diagnosed diseases. A doctor-diagnosed
asthma is based on lung-function test results33,34 and a
doctor-diagnosed AR is based on positive skin prick test
and/or serum specific IgE results. NERD diagnosis was
based on a positive history of wheeze/cough or naso-
ocular symptoms after intake of NSAID, and in 97
patients NERD diagnosis was additionally based on a
positive reaction (wheeze and/or naso-ocular reaction)
after intake of ASA at the hospital.
Baseline ESS was defined as ESS that was performed
within 12months from the sinus CT scans and/or the
baseline visit of sinus surgical consultation, which were
on average one month apart. Previous ESS was defined
as ESS that was performed before the baseline visit of
sinus surgical consultation.
Three predictor variables were used. A.) The propor-
tion of nasal polyp eosinophils of all leukocytes was col-
lected from patient records or from the data of
microscopically evaluated archival nasal polyp speci-
mens as described.35,36 B.) LM score was evaluated
from CT scans by ENT specialists34 blinded to patient
history data. C.) Endoscopic NP score and D.)
Peripheral blood eosinophil count were collected from
patient records. The eosinophilia, LM score and NP
score were performed during the baseline visit before
possible surgery, or at the surgery (NP eosinophilia).
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The NP biopsy had been performed due to clinical pur-
poses to confirm the pathologic diagnosis. The non-
operated patients who were biopsied had undergone
biopsy in local anesthesia at outpatient setting.
Statistics
Statistical analysis was carried out by the SPSS Base 15.0
Statistical Software Package (SPSS Inc., Chicago, IL,
USA). Baseline ESS was used as endpoint. Associations
were assessed by the Fisher’s exact test (dichotomous)
and differences in medians were studied by Kruskal-
Wallis and Mann Whitney U test (continuous). The
three variables were entered into a Receiver Operating
Characteristic (ROC) curve. Predictive performance
was assessed by the area under the receiver operating
characteristic curve (AUROC). Two-tailed P-values of
< 0.05 were considered statistically significant.
Results
Baseline Patient Characteristics
Of the total 378 patients, 192 (50.8%) were female, 165
(43.7%) had patient record history of AR, 248 (65.6%)
had asthma, 182 (48.1%) had NERD, and 59 (15.6%)
were current smokers. At baseline, median age
(min–max) was 48.0 (17–89) years. A hundred and
eighty-five (48.9%) of the patients did not have a
patient-record history of previous ESS. 293 (77.5%)
CRSwNP patients underwent ESS within a year after
the consultation visit.
Comparison of CRSwNP Patients With and Without
the Need of ESS
The operated CRSwNP group had a lower median age
(p < 0.001) (Table 1). The other baseline factors (such as
gender, smoking habits, co-morbidities, previous opera-
tions) did not differ between the groups (Table 1).
The median value of polyp eosinophil proportion was
significantly higher in the operated CRSwNP group
(Figure 1(A)), whereas the median total LM score of
CT scans endoscopic NP score and blood eosinophil
count did not significantly differ between the groups
(Figure 1(B) to (D).
Cut-off Values of Eosinophilia, LM- and NP-Scores
AUROC values (95% CI) for detecting those needing
ESS were for polyp eosinophilia 0.71 (0.60–0.83),
p¼ 0.001, for LM score 0.59 (0.50–0.67), p¼ 0.054; for
NP score 0.56 (0.48–0.64), p¼ 0.17 and, for blood eosin-
ophil count 0.68 (0.46–0.90), p¼ 0.08 (Figure 2). With
the threshold value of polyp eosinophilia >25%, the
sensitivity was 62% and specificity 71% for detecting
the need for ESS. LM score had poor predictive poten-
tial. With the threshold value of LM score 4/24 the
sensitivity was 53% and specificity 56%. Similarly, endo-
scopic NP score had a poor predictive potential. With
the threshold value of NP score 4/8, the sensitivity was
69% and specificity 41%. Peripheral blood eosinophil
count had good, yet statistically insignificant predictive
potential. This might be due to low number of subjects
(N¼ 52) with data available. With the threshold value of
Blood eosinophil count >0.26 109/L, the sensitivity
was 86% and specificity 60%.
Discussion
Finding the best predictors of primary surgery, revision
surgery and uncontrolled disease, and including several
relevant measures in prediction models has been pro-
posed to increase possibilities of precision medicine in
CRS.3,37 In this retrospective cross-sectional real-world
study we wanted to observe radiological, endoscopic and
pathological signs predicting patients undergoing ESS.
We found that elevated nasal polyp eosinophilia, and to
a smaller extent also higher LM score and endoscopic
NP score predicted ESS, despite the fact that at the time
when the study patients have been treated there have





Female, n (%) 37 (43.5) 155 (52.9) .14
Age, median (Q1–Q3) 57.3 (43.8–64.2) 45.6 (35.3–55.7) <.001
Current smoking, n (%) 15 (19.5) 44 (17.1) .61
Allergic rhinitis, n (%) 30 (37.0) 135 (48.0) .099
Asthma, n (%) 57 (67.9) 191 (67.3) 1.00
N-ERD, n (%) 39 (47.6) 143 (50.4) .71
Number of previous ESS, median (Q1-Q3) 1 (0–3) 1 (0–2) .11
CRSwNP patients at the time of undergoing consultation for baseline endoscopic sinus surgery.
NERD¼ patient-reported non-steroidal anti-inflammatory drug -exacerbated respiratory disease; P values by Fishers exact test (dichotomous variables) or
Mann Whitney U test (continuous variables). Q1¼ 25% percentile, Q3¼ 75% percentile.
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been limited literature of predictive factors of uncon-
trolled CRS. Thus the importance of this study was to
replicate the cut-off value of eosinophilia in a hospital
CRS population, who has been treated at the time when
ENT surgeon has not been yet fully aware of cut-off
values of eosinophilia (or other markers) predicting
uncontrolled disease.
We found that only NP eosinophilia was associated
with proceeding to surgery in this clinical cohort of
patients undergoing surgical consultation. The threshold
of >25% of polyp eosinophils was optimal in prediction
surgery, whereas NP score and LM scores were poor in
predicting surgery. This finding is in line with previous
studies from other countries/continents, showing that
tissue eosinophilia predicts revision surgery and polyp
recurrence, and it is also associated with more severe
disease in CRSwNP.3,23–25,38,39 Recently, a recurrence
rate of 48% was shown in patients with CRSwNP with
mucosal eosinophilia using the EPOS definition for
uncontrolled disease.1,24 Few studies have reported cut-
off values of NP eosinophils for uncontrolled CRSwNP,
whether defined by need for surgery, revision surgery or
EPOS criteria for disease control. In a recent study with
136 Chinese CRS patients who had undergone ESS, a
tissue eosinophilia value over 21% was found to be the
best cut-off in prediction of uncontrolled CRS as
assessed by EPOS criteria.3 In a study of 387 Chinese
CRSwNP patients the optimal cut-off percentage value
of nasal polyp eosinophilia was 27% for predicting
polyp recurrence in CRSwNP.30 These findings are
well in line with our results, as in our patients the cut-
off value of >25% in nasal polyp eosinophilia had the
best sensitivity and specificity for prediction of surgery in
CRSwNP. Data of peripheral blood eosinophils was
available only in small number of our patients.
Nevertheless, we detected that peripheral blood eosino-
phil count had relatively good, yet statistically insignifi-
cant predictive potential and, the threshold value
(>0.26 109/L) was similar that has been reported in
Chinese CRSwNP patients (0.3 109/L).29 Studies
with increased subject number in different populations
are still needed to evaluate the role of blood and polyp
eosinophilia.
Results both for and against have been reported on
the ability of LM CT score to predict surgical out-
come.13,21,40–44 In a large prospective study LM CT
score was shown to correlate with polyp grade, symptom
reduction and to some extent with revision rates, but not
with SNOT-22.41 No clear cut-off value in LM CT score
for need of revision surgery could be found. The authors
thought that LM CT score measures different aspects
CRS severity than subjective measurements. Previous
Figure 1. Comparison of the (A) polyp eosinophilia, (B) Lund-Mackay (LM) score of sinus computed tomography (CT) scans, (C)
Endoscopic nasal polyp (NP) score, (D) Peripheral blood eosinophil count, in the chronic rhinosinusitis with nasal polyps (CRSwNP)
patient groups. P-values by Mann Whitney U test.
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studies usually evaluate predictors of revision surgery,
whereas half of our patients underwent primary surgery.
It is possible that as indications for extensive surgery and
revision have been poorly defined, limited surgery has
often been the first choice at least for primary surgery
and radiological severity has not been as important in
the decision making of surgery. This may decrease the
prediction value of LM CT score in this study and per-
haps in previous studies too.
CRSwNP is associated with recurrent disease more
often than CRSsNP.40 High polyp score may increase
the risk for recurrent polyposis.27 However, polyp
score showed to be a poor predictor of ESS in this
study. CRS symptoms and quality of life may have
Figure 2. The Receiver operating characteristic (ROC) discrimination curve of prediction of endoscopic sinus surgery by (A) polyp
eosinophilia, (B) Lund-Mackay (LM) score of sinus computed tomography (CT) scans, (C) Endoscopic nasal polyp (NP) score, (D)
Peripheral blood eosinophil count. AUROC¼ area under the ROC curve. The values in parentheses indicate 95% confidence interval. A,
Polyp eosinophilia had significant predictive potential. With the threshold value of polyp eosinophilia >25% the sensitivity was 62% and
specificity 71% to predict CRS surgery. B, LM score had poor predictive potential. With the threshold value of LM score 14/24 the
sensitivity was 53% and specificity 56%. C, Endoscopic NP score had poor predictive potential. With the threshold value of NP score 4/8
the sensitivity was 69% and specificity 41%. D, Peripheral blood eosinophil count had good, yet statistically insignificant predictive potential.
This might be due to low number of subjects. With the threshold value of Blood eosinophil count >0.26 109/L, the sensitivity was 86%
and specificity 60%.
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been more important when considering surgery. The
patient sample with both previously operated and unop-
erated patients may influence this finding.
The limitations of this study include limited number
of patients having eosinophilia data, and the retrospec-
tive nature of the study, which may make clinical con-
clusions difficult to draw and emphasizes the need for
prospective studies. The sample was not population-
based as the patients were obtained from tertiary care.
Due to the retrospective nature of this study, we could
not confirm the EPOS diagnostic criteria. We acknowl-
edge that lack of patient-reported outcome measure
(e.g., SNOT-22), and lack of some other factors that
have previously been published as criteria of uncon-
trolled CRSwNP1,32 which limits the interpretation of
the findings. On the other hand, due to retrospective
nature of the study the clinicians who had treated
these patients were blinded to the results. We acknowl-
edge that in this real-world setting several factors have
affected the operation decision-making and they might
have included to some extent also variables that were of
our interest. Yet literature-proven cut-off values were
not available or used at that time. Our analysis of sur-
gery may have been influenced by factors unrelated to
recurrence of CRS, including waiting times for surgery
and patients’ preferences to delay surgery for personal
reasons. Other factors that can also affect the timing of
surgery include the patients’ tolerance of rhinosinusitis
symptoms, the operative technique used at the time of
the initial surgery, and the surgeon’s opinion as to when
revision surgery is clinically warranted.
Conclusion
This study demonstrated good prediction for need of
surgical treatment in CRSwNP with >25% nasal polyp
eosinophilia. The role of LM score and polyp score was
not as obvious in this patient sample. Prospective studies
in different populations are still needed.
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